当前位置:首页 - 行情中心 - 千金药业(600479) - 财务分析 - 现金流量表

千金药业

(600479)

  

流通市值:45.16亿  总市值:53.11亿
流通股本:4.19亿   总股本:4.92亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,753,669,163.261,755,790,068.27857,770,105.893,627,441,267.88
  收到其他与经营活动有关的现金165,321,087.9584,855,239.2535,031,976.98411,101,607.36
  经营活动现金流入小计2,918,990,251.211,840,645,307.52892,802,082.874,038,542,875.24
  购买商品、接受劳务支付的现金1,151,404,589.69765,441,144.73375,536,869.181,572,260,744.85
  支付给职工以及为职工支付的现金561,837,345.02416,373,620.7270,570,301.7734,713,852.84
  支付的各项税费244,635,935.85197,025,380.5976,169,912.27347,785,345.1
  支付其他与经营活动有关的现金718,144,004.75506,272,231294,893,912.85985,016,477.85
  经营活动现金流出小计2,676,021,875.311,885,112,377.021,017,170,9963,639,776,420.64
  经营活动产生的现金流量净额242,968,375.9-44,467,069.5-124,368,913.13398,766,454.6
二、投资活动产生的现金流量:
  收回投资收到的现金2,400,0002,400,0002,400,000-
  取得投资收益收到的现金1,513,950117,000-5,746,500
  处置固定资产、无形资产和其他长期资产收回的现金净额205,500205,500-391,520.76
  投资活动现金流入小计4,119,4502,722,5002,400,0006,138,020.76
  购建固定资产、无形资产和其他长期资产支付的现金59,847,063.835,957,906.494,269,256.2647,320,542.82
  投资支付的现金803,000,000390,000,000290,000,000700,000,000
  投资活动现金流出小计862,847,063.8425,957,906.49294,269,256.26747,320,542.82
  投资活动产生的现金流量净额-858,727,613.8-423,235,406.49-291,869,256.26-741,182,522.06
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金5,594,632.235,594,632.232,000,00016,282,452.37
  筹资活动现金流入小计5,594,632.235,594,632.232,000,00016,282,452.37
  偿还债务支付的现金3,000,0003,000,000-46,945,683.75
  分配股利、利润或偿付利息支付的现金155,983,451.814,892,421.01240,000180,456,290.34
  其中:子公司支付给少数股东的股利、利润5,080,0004,840,000240,00027,641,083.04
  支付其他与筹资活动有关的现金16,585,92016,555,920-39,001,798.51
  筹资活动现金流出小计175,569,371.8124,448,341.01240,000266,403,772.6
  筹资活动产生的现金流量净额-169,974,739.58-18,853,708.781,760,000-250,121,320.23
五、现金及现金等价物净增加额-785,733,977.48-486,556,184.77-414,478,169.39-592,537,387.69
  加:期初现金及现金等价物余额1,335,794,750.51,335,794,750.51,335,794,750.51,928,332,138.19
  期末现金及现金等价物余额550,060,773.02849,238,565.73921,316,581.111,335,794,750.5
补充资料:
  净利润-174,035,961.39-302,608,701.01
  资产减值准备-2,038,165.9-7,823,288.98
  固定资产和投资性房地产折旧-28,962,072.51-64,575,449.53
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-28,962,072.51-64,575,449.53
  无形资产摊销-7,165,553.96-13,346,669.42
  长期待摊费用摊销-8,460,032.57-20,900,169.73
  处置固定资产、无形资产和其他长期资产的损失--8,827.08--497,372.67
  固定资产报废损失-123,399.66-451,507.58
  公允价值变动损失--1,372,771.77--634,598.12
  财务费用-36,566.67-4,146,232.03
  投资损失--18,803,638.62--15,582,312.28
  递延所得税--2,556,479.55--1,363,127.55
  其中:递延所得税资产减少--5,912,925.48-5,693,151.56
    递延所得税负债增加-3,356,445.93--7,056,279.11
  存货的减少-44,537,350.31-44,607,230.46
  经营性应收项目的减少--361,639,594.53-18,729,574.94
  经营性应付项目的增加-52,380,038.56--147,803,143.32
  其他---60,884,469.84
  现金的期末余额-849,238,565.73-1,335,794,750.5
  减:现金的期初余额-1,335,794,750.5-1,928,332,138.19
  现金及现金等价物的净增加额--486,556,184.77--592,537,387.69
公告日期2025-10-302025-08-302025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑